Status:
RECRUITING
Treatment to Promote Self-regulation in Children With Autism Spectrum Disorder
Lead Sponsor:
Holland Bloorview Kids Rehabilitation Hospital
Collaborating Sponsors:
Centre for Addiction and Mental Health
University of Toronto
Conditions:
Autism Spectrum Disorder
Self-Regulation, Emotion
Eligibility:
All Genders
9-18 years
Phase:
PHASE2
Brief Summary
This study will evaluate the feasibility of repetitive Transcranial Magnetic Stimulation (rTMS) in Autism Spectrum Disorder (ASD) with self-regulation impairment. Baseline and follow-up participant vi...
Detailed Description
Children and youth with Autism Spectrum Disorder (ASD) often present with co-morbid impairments in self-regulation (e.g., difficulty managing their emotions) resulting in unhelpful regulatory approach...
Eligibility Criteria
Inclusion
- Children with a diagnosis of autism spectrum disorder and self-regulation impairment or challenges
- Able to participate in rTMS
Exclusion
- Children with autism spectrum disorder but no co-morbid self-regulation disorders.
- Children with contraindications to TMS (history of seizures, family history of seizures, metal implants)
- Co-existing neurological conditions (epilepsy, stroke, etc.)
Key Trial Info
Start Date :
September 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05235919
Start Date
September 22 2022
End Date
February 1 2025
Last Update
July 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bloorivew Research Institute
Toronto, Ontario, Canada, M4G 1R8